237 related articles for article (PubMed ID: 38612531)
1. Infant Acute Lymphoblastic Leukemia-New Therapeutic Opportunities.
Kulczycka M; Derlatka K; Tasior J; Sygacz M; Lejman M; Zawitkowska J
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612531
[TBL] [Abstract][Full Text] [Related]
2. Updates in the biology and therapy for infant acute lymphoblastic leukemia.
Guest EM; Stam RW
Curr Opin Pediatr; 2017 Feb; 29(1):20-26. PubMed ID: 27841777
[TBL] [Abstract][Full Text] [Related]
3. Updates in infant acute lymphoblastic leukemia and the potential for targeted therapy.
Kotecha RS
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):611-617. PubMed ID: 36485124
[TBL] [Abstract][Full Text] [Related]
4. Evolution and optimization of therapies for acute lymphoblastic leukemia in infants.
Tomizawa D
Int J Hematol; 2023 Feb; 117(2):162-172. PubMed ID: 36441356
[TBL] [Abstract][Full Text] [Related]
5. Acute Leukemia in Infants.
Ibrahimova A; Pommert L; Breese EH
Curr Oncol Rep; 2021 Feb; 23(3):27. PubMed ID: 33580326
[TBL] [Abstract][Full Text] [Related]
6. Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia-Therapy and Toxicity Mechanisms.
Lejman M; Kuśmierczuk K; Bednarz K; Ostapińska K; Zawitkowska J
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575992
[TBL] [Abstract][Full Text] [Related]
7. Acute lymphoblastic leukemia in infants: A quarter century of nationwide efforts in Japan.
Tomizawa D; Miyamura T; Koh K; Ishii E
Pediatr Int; 2022 Jan; 64(1):e14935. PubMed ID: 34324764
[TBL] [Abstract][Full Text] [Related]
8. Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemia.
Chen C; Yu W; Alikarami F; Qiu Q; Chen CH; Flournoy J; Gao P; Uzun Y; Fang L; Davenport JW; Hu Y; Zhu Q; Wang K; Libbrecht C; Felmeister A; Rozich I; Ding YY; Hunger SP; Felix CA; Wu H; Brown PA; Guest EM; Barrett DM; Bernt KM; Tan K
Blood; 2022 Apr; 139(14):2198-2211. PubMed ID: 34864916
[TBL] [Abstract][Full Text] [Related]
9. Cryptic and atypical KMT2A-USP2 and KMT2A-USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia.
Blackburn PR; Smadbeck JB; Znoyko I; Webley MR; Pitel BA; Vasmatzis G; Xu X; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Lindsey KG; Schandl CA; Wolff DJ; Peterson JF
Genes Chromosomes Cancer; 2020 Jul; 59(7):422-427. PubMed ID: 32196814
[TBL] [Abstract][Full Text] [Related]
10. Cryptic recurrent ACIN1-NUTM1 fusions in non-KMT2A-rearranged infant acute lymphoblastic leukemia.
Pincez T; Landry JR; Roussy M; Jouan L; Bilodeau M; Laramée L; Couture F; Sinnett D; Gendron P; Hébert J; Oligny L; Rouette A; Tran TH; Wilhelm BT; Bittencourt H; Cellot S
Genes Chromosomes Cancer; 2020 Feb; 59(2):125-130. PubMed ID: 31515871
[TBL] [Abstract][Full Text] [Related]
11. Molecular-based and antibody-based targeted pharmacological approaches in childhood acute lymphoblastic leukemia.
Tardif M; Souza A; Krajinovic M; Bittencourt H; Tran TH
Expert Opin Pharmacother; 2021 Oct; 22(14):1871-1887. PubMed ID: 34011251
[No Abstract] [Full Text] [Related]
12. Use of CD19-directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia.
Breese EH; Krupski C; Nelson AS; Perentesis JP; Phillips CL
J Pediatr Hematol Oncol; 2021 May; 43(4):152-154. PubMed ID: 32496443
[TBL] [Abstract][Full Text] [Related]
13. Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia.
Khabirova E; Jardine L; Coorens THH; Webb S; Treger TD; Engelbert J; Porter T; Prigmore E; Collord G; Piapi A; Teichmann SA; Inglott S; Williams O; Heidenreich O; Young MD; Straathof K; Bomken S; Bartram J; Haniffa M; Behjati S
Nat Med; 2022 Apr; 28(4):743-751. PubMed ID: 35288693
[TBL] [Abstract][Full Text] [Related]
14. Relapsed childhood acute lymphoblastic leukaemia.
Bhojwani D; Pui CH
Lancet Oncol; 2013 May; 14(6):e205-17. PubMed ID: 23639321
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas9 Library Screening Identifies Novel Molecular Vulnerabilities in
Schneider P; Wander P; Arentsen-Peters STCJM; Vrenken KS; Rockx-Brouwer D; Adriaanse FRS; Hoeve V; Paassen I; Drost J; Pieters R; Stam RW
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686014
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.
Huang YH; Wan CL; Dai HP; Xue SL
Ann Hematol; 2023 Aug; 102(8):2001-2013. PubMed ID: 37227492
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a t(11;19), KMT2A Rearranged B-ALL Cell Line for Preclinical Evaluation and Novel Therapeutics Development for Refractory Infant Leukemia.
Sharma R; Incoronato A; Zhang C; Jayanthan A; Shah R; Narendran A
J Pediatr Hematol Oncol; 2023 Aug; 45(6):e750-e756. PubMed ID: 37494611
[TBL] [Abstract][Full Text] [Related]
18. HMGA2 as a potential molecular target in KMT2A-AFF1-positive infant acute lymphoblastic leukaemia.
Wu Z; Eguchi-Ishimae M; Yagi C; Iwabuki H; Gao W; Tauchi H; Inukai T; Sugita K; Ishii E; Eguchi M
Br J Haematol; 2015 Dec; 171(5):818-29. PubMed ID: 26403224
[TBL] [Abstract][Full Text] [Related]
19. Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.
Urtishak KA; Wang LS; Culjkovic-Kraljacic B; Davenport JW; Porazzi P; Vincent TL; Teachey DT; Tasian SK; Moore JS; Seif AE; Jin S; Barrett JS; Robinson BW; Chen IL; Harvey RC; Carroll MP; Carroll AJ; Heerema NA; Devidas M; Dreyer ZE; Hilden JM; Hunger SP; Willman CL; Borden KLB; Felix CA
Oncogene; 2019 Mar; 38(13):2241-2262. PubMed ID: 30478448
[TBL] [Abstract][Full Text] [Related]
20. [Acute leukemia of infants and neonates].
Eguchi M
Rinsho Ketsueki; 2021; 62(8):1308-1318. PubMed ID: 34497221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]